Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Jul 2008
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 23 Jul 2008 The expected completion date for this trial is now 1 Jan 2008.
- 21 Apr 2008 New trial record.
- 18 Apr 2008 Status change from recruiting to in progress, according to clinicaltrials.gov.